Eva Kimby

14.5k total citations
203 papers, 7.7k citations indexed

About

Eva Kimby is a scholar working on Pathology and Forensic Medicine, Genetics and Immunology. According to data from OpenAlex, Eva Kimby has authored 203 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Pathology and Forensic Medicine, 116 papers in Genetics and 73 papers in Immunology. Recurrent topics in Eva Kimby's work include Lymphoma Diagnosis and Treatment (153 papers), Chronic Lymphocytic Leukemia Research (115 papers) and Immunodeficiency and Autoimmune Disorders (46 papers). Eva Kimby is often cited by papers focused on Lymphoma Diagnosis and Treatment (153 papers), Chronic Lymphocytic Leukemia Research (115 papers) and Immunodeficiency and Autoimmune Disorders (46 papers). Eva Kimby collaborates with scholars based in Sweden, United States and United Kingdom. Eva Kimby's co-authors include Birger Christensson, Birgitta Sander, Håkan Mellstedt, Björn E. Wahlin, Anders Österborg, Harald Holte, Steven P. Treon, Jeanette Lundin, Magnus Björkholm and Robert Marcus and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Eva Kimby

197 papers receiving 7.6k citations

Peers

Countries citing papers authored by Eva Kimby

Since Specialization

Citations

This map shows the geographic impact of Eva Kimby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Kimby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Kimby more than expected).

Fields of papers citing papers by Eva Kimby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Kimby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Kimby. The network helps show where Eva Kimby may publish in the future.

Co-authorship network of co-authors of Eva Kimby

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Kimby. A scholar is included among the top collaborators of Eva Kimby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Kimby. Eva Kimby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Report of Consensus Panel 2 from the 12th International Workshop on the management of Bing-Neel syndrome in patients with Waldenstrom’s Macroglobulinemia 2025 ·Seminars in Hematology ·Shayna Sarosiek, (unknown), Andrew R. Branagan, Simone Ferrero, Jahanzaib Khwaja, Eva Kimby, Damien Roos‐Weil, Naohiro Sekiguchi, Marek Trněný, Shuhua Yi, Christopher J. Patterson, Christian Buske, Jeffrey Matous, Steven P. Treon, Monique C. Minnema	0
2	Personalised therapy in follicular lymphoma – is the dial turning? 2023 ·Hematological Oncology ·Kim Linton, Lena Specht, Astrid Pavlovsky, Carrie A. Thompson, Eva Kimby, Daphne de Jong, Loretta J. Nastoupil, Anne‐Ségolène Cottereau, Carla Casulo, Clémentine Sarkozy, Jessica Okosun	4
3	Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia 2023 ·Vaccine ·(unknown), Bertil Uggla, Elisabet Tina, Eva Kimby, Torbjörn Norén, (unknown)	0
4	Career development: A balance of opportunities and choices 2023 ·Hematological Oncology ·Daphne de Jong, Eva Kimby, Lena Specht	2
5	Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials 2021 ·Blood Advances ·Carla Casulo, Jesse G. Dixon, Fang‐Shu Ou, Eva Hoster, B. A. Peterson, Howard S. Höchster, Pauline Brice, Marco Ladetto, Wolfgang Hiddemann, Robert Marcus, Eva Kimby, Michael Herold, Tina Nielsen, Franck Morschhauser, Mathias Rummel, Anton Hagenbeek, Umberto Vitolo, Gilles Salles, Qian Shi, Christopher R. Flowers	3
6	Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial 2021 ·Bone Marrow Transplantation ·Ruth Pettengell, (unknown), Ariane Boumendil, Roderick J. Johnson, Bernd Metzner, Alejandro Martı́n, Joanna Romejko‐Jarosińska, Isabelle Bence‐Bruckler, (unknown), Carsten Utoft Niemann, Stephen Robinson, Eva Kimby, Norbert Schmitz, Peter Dreger, A. H. Goldstone, Silvia Montoto	7
7	TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma 2019 ·Cancer Immunology Research ·(unknown), Klaus Beiske, Yngvild Nuvin Blaker, (unknown), Harald Holte, Bjørn Østenstad, Eva Kimby, Hakan Köksal, Sébastien Wälchli, Baoyan Bai, Erlend B. Smeland, Ronald Levy, Arne Kolstad, Kanutte Huse, June H. Myklebust	82
8	First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013 2018 ·Haematologica ·(unknown), (unknown), Hemming Johansson, Jenny Klintman, (unknown), (unknown), Eva Kimby, Stefan Norin, Per‐Ola Andersson, Claes Karlsson, Karin Karlsson, Birgitta Lauri, Mattias Mattsson, Anna Sandstedt, Maria Strandberg, Anders Österborg, Lotta Hansson	28
9	Outcome of Patients with Chronic Lymphocytic Leukemia (CLL) Receiving First Line Therapy: A Swedish Nation-Wide Study on 1053 Consecutive Patients Treated between 2007 and 2013 2017 ·Blood ·(unknown), (unknown), Hemming Johansson, Jenny Klintman, (unknown), (unknown), Eva Kimby, Stefan Norin, (unknown), Claes Karlsson, Karin Karlsson, Birgitta Lauri, Mattias Mattsson, Anna Sandstedt, Maria Strandberg, Anders Österborg, Lotta Hansson	1
10	T-Cell Levels Are Prognostic in Mantle Cell Lymphoma 2014 ·Clinical Cancer Research ·Lina Nygren, Agata M. Wasik, (unknown), (unknown), Monika Klimkowska, Patrik Andersson, (unknown), Birger Christensson, Eva Kimby, Björn E. Wahlin, Birgitta Sander	34
11	Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation 2013 ·Journal of Clinical Oncology ·Ruth Pettengell, Norbert Schmitz, Christian Gisselbrecht, Graeme Smith, W. N. Patton, Bernd Metzner, Dolores Caballero, Hervé Tilly, Jan Walewski, Isabelle Bence‐Bruckler, Bik To, Christian H. Geisler, Rik Schots, Eva Kimby, Christian Taverna, Tomáš Kozák, Peter Dreger, Ruzena Uddin, Carmen Ruiz de Elvira, Anthony H. Goldstone	77
12	Ofatumumab + Chlorambucil Versus Chlorambucil Alone In Patients With Untreated Chronic Lymphocytic Leukemia (CLL): Results Of The Phase III Study Complement 1 (OMB110911) 2013 ·Blood ·Peter Hillmen, Tadeusz Robak, Ann Janssens, (unknown), Sebastian Grosicki, Jiřı́ Mayer, Panagiotis Panagiotidis, Eva Kimby, Anna Schuh, Thomas E. Boyd, Marco Montillo, Astrid McKeown, Jodi Carey, Ira Gupta, Chai‐Ni Chang, Steen Lisby, Fritz Offner	58
13	T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab 2011 ·Clinical Cancer Research ·Björn E. Wahlin, Christer Sundström, Harald Holte, Hans Hagberg, Martin Erlanson, Herman Nilsson‐Ehle, Ola Lindén, Marie Nordström, Bjørn Østenstad, Christian H. Geisler, Peter de Nully Brown, Tuula Lehtinen, (unknown), Anne Tierens, Birgitta Sander, Birger Christensson, Eva Kimby	41
14	FCGR3A polymorphism does not significantly affect response and outcome of follicular lymphoma patients treated in the PRIMA study with rituximab and chemotherapy followed by rituximab maintenance or observation 2011 ·Annals of Oncology ·Eva Kimby, Adriana Scheliga, Jiří Mayer, Fritz Offner, Adriana Teixeira, Kazimierz Kuliczkowski, A.M. Liberati, (unknown), Dixie-Lee Esseltine, Panteli Theocharous, (unknown), H. Van de Velde, (unknown), Bertrand Coiffier	1
15	BCL-2/IgH Polymerase Chain Reaction Status at the End of Induction Treatment Is Not Predictive for Progression-Free Survival in Relapsed/Resistant Follicular Lymphoma: Results of a Prospective Randomized EORTC 20981 Phase III Intergroup Study 2010 ·Journal of Clinical Oncology ·Marinus H. J. van Oers, Evelyn Tönnissen, M. van Glabbeke, L. Giurgea, Joop H. Jansen, Richard Klasa, Robert Marcus, Max Wolf, Eva Kimby, Andrej Vranovský, Harald Holte, Anton Hagenbeek, Bert A. van der Reijden	34
16	High‐resolution genomic screening in mantle cell lymphoma—specific changes correlate with genomic complexity, the proliferation signature and survival 2010 ·Genes Chromosomes and Cancer ·Anna Margrét Halldórsdóttir, Birgitta Sander, Hanna Göransson, Anders Isaksson, Eva Kimby, Mahmoud Mansouri, Richard Rosenquist, Hans Ehrencrona	19
17	Tumor burden status evaluated by computed tomography scan is of prognostic importance in patients with chronic lymphocytic leukemia 2009 ·Medical Oncology ·Stefan Norin, Eva Kimby, Jeanette Lundin	10
18	Tolerability and safety of rituximab (MabThera 2006 ·Oncology in Clinical Practice ·Eva Kimby	25
19	Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL). 2001 ·Blood ·Jeanette Lundin, Eva Kimby, Magnus Björkholm, Fredrik Celsing, G Hale, Viktoria Hjalmar, Mats Merup, (unknown), (unknown), Herman Waldmann, Håkan Mellstedt, Anders Österborg	4
20	The Swedish Council on Technology Assessment in Health Care (SBU) Systematic Overview of Chemotherapy Effects in Some Major Tumour Types - Summary and Conclusions 2001 ·Acta Oncologica ·Ingrid Glimelius, Jonas Bergh, L. Brandt, Bengt Brorsson, Barbro Gunnars, Larsolof Hafström, U Haglund, Thomas Högberg, (unknown), Per‐Ebbe Jönsson, Göran Karlsson, Eva Kimby, (unknown), Sten Nilsson, Johan Permert, Peter Ragnhammar, Sverre Sörenson, Peter Nygren	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact